cancer screening guideline

(redirected from Breast CA)

cancer screening guideline

Any guideline promulgated by an authoritative organisation (e.g., the American Cancer Society) for early detection of a malignancy which is common in a particular demographic, the diagnosis of which, if caught early, results in a complete cure or improved long-term survival.

Cancer screening guidelines
• Breast CA—Self-breast examination on a monthly basis, a baseline mammogram at age 40 and mammography every 1–2 years thereafter, depending on risk factors. 
• Colorectal CA—Per NCI, Am. Cancer Society, and Am. College of Physicians: annual feacal occult blood test > age 40 and flexible sigmoidoscopy every 3–5 years > age 50.
• Prostate CA—Annual digital rectal examination after age 40, and measurement of PSA in serum. 
• Uterine cervix—Annual Pap smear and pelvic examination after initiation of sexual activity; after 3 normal years, the test may be reduced in frequency at the discretion of the patient’s physician.
Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.

cancer screening guideline

Any guideline promulgated by an authoritative organization–eg Am Cancer Society, for early detection of a malignancy common in a particular population, the diagnosis of which, if caught early, results in a complete cure or improved long-term survival. See Cancer screening, Cancer screening test; Cf Unproven methods for cancer management.
Cancer screening guidelines
Breast CA
Self-breast examination on a monthly basis, a baseline mammogram at age 40 and mammography every 1-2 years thereafter, depending on risk factors
Colorectal CA
Per NCI, Am Cancer Society, and Am College of Physicians–annual fecal occult blood test > age 40 and flexible sigmoidoscopy every 3-5 years > age 50 (NEJM 1991; 325:37)
Prostate CA
Annual digital rectal examination after age 40, and measurement of prostate-specific antigen or acid phosphatase in the serum
Uterine cervix
Annual Pap smear and pelvic examination after initiation of sexual activity; after 3 normal years, the test may be reduced in frequency at the discretion of the Pt's physician
.
McGraw-Hill Concise Dictionary of Modern Medicine. © 2002 by The McGraw-Hill Companies, Inc.
References in periodicals archive ?
The most common Ca include breast Ca 37 (24.7) followed by blood related Ca 36 (24).
Should a KS patient be subjected to an early screening for breast CA (mammography/MRI), colonic CA (endoscopy), endometrial CA, and lung CA?
This report describes differential diagnosis of a parotid lipoma in a breast CA patient detected with advanced imaging methods such as US and contrast tomography.
Table 3: Age distribution of Patients of Breast CA.
No recurrent breast ca; multiple tiny to mid-thigh osteoblastic metastasis throughout vertebral column, pelvic bones, sternum, ribs, proximal femur, and humeri ii.
In an attempt to spread awareness about the experience of advanced breast ca ncer patients, the "I Am Not The Cancer" art installation supported by Friends of Cancer Patients (FoCP) charity was unveiled on Wednesday.
Anastacia, include I'm O Left Outsi first dia breast ca She conditi heart episod much norm An bat d also has a condition where her heart can have episodes of beating faster than normal.
For this year's Breast Ca | ncer Awareness Month, Breast Cancer Care is aiming to | highlight the body | confidence | problems | so common for people the disease, | and the help available to them.
1[degrees] (Gy) Dx 1 F L breast CA 50 L/RT/Raloxifene 60 2 F L breast CA 57 L/RT 64.6 3 F L breast CA 70 L/RT 60 4 F R breast CA 50 L/RT 61 5 F R breast CA 74 L/RT/Tm 52 6 F R breast CA 53 L/C/RT/Tm 64.6 7 F L breast CA 51 L/C/RT 54 8 F SCC,R Cheek 68 WLE/RT 70.2 9 M Seminoma 26 WLE/RT Co x 6 wks 10 M Prostate CA 72 WLE/RT 72 11 F Hodgkin's 16 C/total nodal RT NA lymphoma Case Interval RAA Tx Status Interval to no.
* Women with ER-positive breast Ca may soon extend tamoxifen therapy to 10 years
Table 1: Combination of DF and VC on Growth of Various Cancer Cells Cell Growth (% of Control) at 3 Days Cancer Cell Lines Treatment with DF (300 [micro]g/m1) + VC (200 [micro]M) MDA-MB231 (Breast Ca) <5% (>95% [down arrow]) * A549 (Lung Ca) 30% (70% [down arrow]) AGS (Stomach Ca) <5% (>95% [down arrow]) Urologic Cancers: PC-3 (Prostate Ca) <5% (>95% [down arrow]) T24 (Bladder Ca) <10% (>90% [down arrow]) ACHN (Renal Cell Ca) 10% (90% [down arrow]) Breast Cancers (Additional): MCF-7 10% (90% [down arrow]) ZR-75-1 <5% (>95% [down arrow]) T-47D <10% (>90% [down arrow]) * Values in parentheses are the % of growth reduction relative to control (0%).
Mammographies, Ultrasound, Cytological assessment with Fine Needle Aspiration Cytology (FNAC) etc are having a role to diagnose breast CA and to help in management though improper and having errors.